LXRX
Lexicon Pharmaceuticals Inc
1.80$
+0.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +889.7% | +8.7% | -15.9% | +40.9% | -25.4% | +3.2% | -13.0% | +94.1% | -29.2% | -1.4% | +42.3% | +17.3% | -13.6% | -26.3% | +71.9% | +38.9% | -27.4% | -8.2% | -34.9% | +47.0% | -51.2% | -32.8% | +41.9% | +18.1% | +30.1% | -38.0% | |
| – | +1,535.2% | -19.2% | -20.0% | +28.8% | -42.4% | +7.4% | -19.3% | +209.3% | -58.8% | +55.4% | +26.6% | +31.2% | -18.0% | -41.7% | +174.2% | +44.3% | -32.8% | -10.0% | -46.2% | +94.9% | -53.3% | -43.6% | +58.4% | +25.3% | +39.4% | -58.6% | |
| – | +1,790.6% | -39.0% | +70.8% | +108.1% | -82.2% | +50.4% | +37.6% | -24.1% | +274.4% | +17.1% | -53.1% | +496.7% | -20.8% | -42.1% | +162.8% | +53.6% | -33.5% | -10.3% | -48.5% | -77.4% | +249.6% | -49.3% | -27.7% | -51.5% | +196.7% | -48.5% | |
| – | +2,127.3% | -22.8% | -40.2% | +11.1% | -15.8% | +13.9% | -19.8% | +223.5% | -60.2% | +57.6% | +29.9% | +33.4% | -20.8% | -42.1% | +162.8% | +53.6% | -33.5% | -10.3% | -48.5% | +69.7% | -43.9% | -43.0% | +59.5% | +22.9% | +40.0% | -59.6% | |
| – | -17.0% | +61.4% | +13.2% | +27.8% | -2.6% | -59.2% | -54.5% | +48.7% | -67.8% | +43.5% | -8.7% | -53.0% | +293.7% | -42.7% | +31.0% | -12.0% | +722.4% | -35.6% | +22.8% | +854.3% | -99.3% | -96.5% | +100.0% | +3,507.1% | +243.9% | -31.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +476,399,900.0% | -100.0% | -100.0% | – | +140.2% | -9.3% | -100.0% | – | – | – | -39.4% | +21.6% | |
| – | – | +84.5% | +39.9% | +124.0% | +1.1% | +0.8% | -8.3% | -9.4% | -8.1% | -9.7% | -9.1% | -13.1% | -8.2% | -3.0% | -97.4% | +1,865.5% | -8.7% | -8.8% | -10.3% | -11.5% | -97.9% | +298.6% | +76.1% | – | – | – | |
| – | – | – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +72.7% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | – | – | +452.2% | -4.0% | -4.2% | -4.3% | -2.4% | +0.0% | +0.0% | +0.0% | +107.6% | +0.0% | +0.0% | +0.0% | -0.4% | +0.0% | +0.0% | -2.8% | -3.4% | -60.7% | – | – | – | – | – | – | |
| – | -7.3% | +65.5% | +47.4% | +270.2% | -23.4% | +47.0% | -21.2% | -21.0% | -20.6% | +43.5% | +27.2% | +10.9% | -20.9% | -1.0% | +80.2% | +96.9% | -13.8% | +20.8% | -19.2% | -3.2% | -84.2% | -50.8% | +231.0% | +76.6% | +11.8% | -49.2% | |
| – | +5.9% | +67.2% | +13.4% | +49.1% | +21.9% | +48.4% | -20.0% | -23.1% | -40.1% | +140.6% | -78.9% | +131.0% | -26.5% | +5.5% | +133.1% | +173.5% | +33.9% | -24.6% | -70.4% | +77.8% | -28.4% | -52.7% | +4.7% | +36.1% | +43.4% | -53.9% | |
| – | -89.2% | – | – | – | – | +1.3% | -82.8% | +7.8% | +9.4% | +3,896.1% | -97.0% | +2,087.5% | -129.5% | – | – | -326.7% | – | – | -798.8% | – | +5.5% | -91.1% | +18.5% | +0.0% | -9.0% | +430.8% | |
| – | +111.7% | +25.6% | +38.2% | +34.4% | +28.7% | -9.1% | -5.4% | +12.8% | +7.9% | -25.3% | -46.6% | +91.3% | +26.8% | +26.8% | +34.5% | +51.0% | +168.1% | -26.7% | -68.9% | +1.0% | -55.1% | +67.3% | +13.6% | +38.4% | +2.9% | -79.2% | |
| – | – | – | – | +1,308.6% | -41.5% | -2.3% | -2.5% | -2.8% | -3.2% | -3.5% | -4.0% | -14.2% | -6.7% | -7.8% | +333.9% | +18.6% | -17.9% | +171.9% | +5.3% | -4.0% | – | – | – | +104.8% | +0.8% | -50.7% | |
| – | +2,432.1% | +5.2% | -22.2% | -2.2% | -26.8% | -29.4% | -0.4% | +199.8% | -27.6% | -11.7% | +50.8% | +20.5% | -10.4% | -476.5% | – | +0.6% | -44.9% | -66.9% | -2,924.4% | – | +33.5% | -27.4% | +3.1% | -20.5% | +56.8% | -26.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +69.7% | +20.7% | +4.1% | +8.7% | +11.5% | +1.0% | +4.6% | +49.2% | +37.1% | +6.3% | +108.2% | +12.5% | +43.7% | +4.8% | +4.2% | +35.7% | +0.3% | +1.3% | +0.6% | +10.3% | -5.1% | +31.4% | +13.8% | +33.4% | +44.7% | +13.4% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.